Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Clin Cancer Res. 2019 Sep 16;25(24):7396–7404. doi: 10.1158/1078-0432.CCR-19-0740

Figure 2.

Figure 2.

Beta-actin corrected methylation intensity in DNA markers assayed from plasma.

Each column on the x-axis represents an individual patient’s sample; each row on the y-axis represents the methylation specific PCR product by QuARTS assay for each marker on a logarithmic scale. A 91% specificity threshold was selected by the rPart model. Increasing yellow-red color spectrum reflects increasing methylation intensity above the 91st percentile value of the control patient samples.